Rezolute Inc (RZLT NASDAQ) stock market data APIs
$3.8962
0.18(4.6%)
as of June 9, 2026
Try our APIs with
free plan!
Rezolute Inc Financial Data Overview
Price chart is built with
Anychart
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Prev. Close
3.8962
Open
4.0769
High
4.0869
Low
3.6755
52 wk Range
1.07-11.457
Market Cap
376 M
Shares Outstanding
96 292 K
EPS
-0.1554
Beta
0.65
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Rezolute Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rezolute Inc data using free add-ons & libraries
Get Rezolute Inc Fundamental Data
Rezolute Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -85 823 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-13
- EPS/Forecast: -0.1689
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rezolute Inc News
New
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
Shares of Rezolute RZLT rose 38% over the past week, driven by positive interim results from the late-stage upLIFT study evaluating its lead candidate, ersodetug, in patients with tumor hyperinsulinis...
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society
REDWOOD CITY, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage ultra-rare disease company focused on treating refractory hy...
Top Biotech Gainers: ABVX, CING, DRTS, MMED...
(RTTNews) - Today's gainers list includes ABIVAX, which recently announced positive ulcerative colitis trial results; Cingulate, which is working toward resubmission of a New Drug Application for an A...
Rezolute upgraded at Citizens after late-stage trial data for lead asset
[Wall Street New York stock exchange stock market] alexsl Rezolute (RZLT [https://seekingalpha.com/symbol/RZLT]) traded higher for the third straight session on Wednesday after Citizens JMP Securitie...
Get Rezolute Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
